Distribution of metallothionein in the human central nervous system

Blaauwgeers, Hans; Smitt, Peter A.E. Sillevis; Jong, J.M.B.V. de; Troost, Dirk

doi:10.1002/glia.440080108

Cited by 78 publications

(38 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In accordance with the present study, most studies on MT expression in CNS describe the absence or scarcity of w x MT-immunopositive neurons 8,42,43,66 . On the other w x hand, by using polyclonal antibodies, Hidalgo et al 28 found MT immunoreactivity in neurons of different rat cerebral and cerebellar areas.…”

Section: Distribution Of Mt In Normal Animalssupporting

confidence: 91%

Induction of metallothionein in astrocytes and microglia in the spinal cord from the myelin-deficient jimpy mouse

et al. 1997

View full text Add to dashboard Cite

Jimpy is a shortened life-span murine mutant whose genetic disorder results in severe pathological alterations in the CNS, including Ž . hypomyelination, oligodendrocyte death and strong astroglial and microglial reaction. The knowledge of metallothionein MT regulation in the CNS and especially of MT presence in specific glial cell types under pathological conditions is scarce. In the present study, immunocytochemical detection of MT-I q II has been performed in spinal cord sections from 10-12-and 20-22-day-old jimpy and normal animals. The identification of MT-positive glial cells was achieved through double labeling combining MT immunocytochemistry and selective markers for oligodendrocytes, astrocytes and microglia. MT was found in glial cells and was present in the spinal cord of jimpy and normal mice at both ages, but there were remarkable differences in MT expression and in the nature of MT-positive glial cells depending on the type of mouse. The number of MT-positive cells was higher in jimpy than in normal spinal cords. This was apparent in all spinal cord areas, although it was more pronounced in white than in the gray matter and at 20-22 days than at 10-12 days. The mean Ž . Ž . number of MT-positive glia in the jimpy white matter was 1.9-fold 10-12 days and 2.4-fold 20-22 days higher than in the normal one. Astrocytes were the only parenchymal glial cells that were positively identified as MT-producing cells in normal animals. Interestingly, MT in the jimpy spinal cord was localized not only in astrocytes but also in microglial cells. The occurrence of MT induction in relation to reactive astrocytes and microglia, and its role in neuropathological conditions is discussed. q 1997 Elsevier Science B.V.

show abstract

Section: Distribution Of Mt In Normal Animalssupporting

confidence: 91%

Induction of metallothionein in astrocytes and microglia in the spinal cord from the myelin-deficient jimpy mouse

et al. 1997

View full text Add to dashboard Cite

show abstract

“…The findings agreed with those reported in the brain of humans [3,27,28], monkeys [26], rats [14,32] and mice [12,14]. Intense MT-I & -II immunoreactivity was observed in astrocytes in the periventricular area and those around the blood vessels, indicating that MT-I & -II may play a role as a barrier against the toxic substances including metals.…”

Section: Discussionsupporting

confidence: 90%

“…Immunohistochemical localization of MT-I & -II in the brain has been reported in humans [3,27,28], monkeys [26], mice [12,14] and rats [14,32]; MT-I & -II were shown in choroid plexus epithelial cells, ependymal cells, pia mater, and astrocytes in the hypothalamus, hippocampus, cerebral cortex and white matter throughout the brain. With at 5 µm were stained with hematoxylin and eosin (HE) and periodic acid methenamine silver (PAM).…”

Section: Animalsmentioning

confidence: 94%

Localization of Metallothioneins-I & -II and -III in the Brain of Aged Dog.

Kojima

Shimada

Morita

et al. 1999

The Journal of Veterinary Medical Science

View full text Add to dashboard Cite

ABSTRACT. Localization of metallothionein (MT) -I & -II and MT-III and its significance in the brain aging in dogs were examined using immunohistological and molecular pathological techniques. MT-I & -II immunohistochemistry showed positive staining in the hypertrophic astrocytes throughout the aged dog brains; these MT-I & -II immunoreactive astrocytes were predominant in the cerebral cortex and around the blood vessels in the brain. These findings dominated in the brain regions with severe age-related morphological changes. In situ hybridization using MT-I mRNA riboprobes also demonstrated signals for MT-I mRNA in these hypertrophic astrocytes. Immunohistochemistry using a guinea pig antiserum against a synthetic polypeptide of canine MT-III demonstrated positive MT-III immunoreactivity predominantly in neurons in the Zn-rich regions such as hippocampus and parahippocampus. The findings were supported by in situ hybridization using MT-III mRNA riboprobes. Both MT-III immunoreactivity and signals for MT-III mRNA were demonstrated in neurons in the brain regardless of the intensity of the age-related changes. These results suggest, first, MT-I & -II may be induced in relation to the progress of the age-related morphological changes in the brain, playing an important role in the protection of the brain tissue from the toxic insults responsible for the brain aging, and second, MT-III may play a role in maintenance of Zn-related essential functions of the brain.-KEY WORDS: aging, brain, canine, in situ hybridization, metallothionein.

show abstract

“…Mammalian MT family consists of four similar but distinct isoforms, designated MT-I, -II, -III and -IV [18,21]. MT-I and -II are expressed in astrocytes in the central nervous system (CNS) [2,16,[22][23][24]27]. It is generally agreed that MTs play important roles in the homeostasis of essential metals including zinc and copper, in the detoxification of heavy metals, and in the scavenging of free radicals [5,11].…”

Section: Animalsmentioning

confidence: 99%

Localization of Metallothionein-I and -II in Hypertrophic Astrocytes in Brain Lesions of Dogs.

Shimada

Uemura

Yamamura

et al. 1998

The Journal of Veterinary Medical Science

View full text Add to dashboard Cite

ABSTRACT. To study the neurophysiological functions of metallothioneins (MTs), localization of MT-I and -II was examined immunohistochemically in a variety of brain lesions in dogs, including infarct, laminar cortical necrosis, hemorrhage, invasive growth of tumour, inflammatory lesions in granulomatous meningoencephalitis and distemper encephalitis. MT-I and -II were demonstrated in both nucleus and cytoplasm of hypertrophic astrocytes in most brain lesions examined regardless of the type, size, localization and duration of the lesions. In addition, MT expression was stronger in a population of hypertrophic astrocytes localizing inside of the surviving brain tissue rather than those localizing at the boundary between the surviving brain tissue and necrotic area, where severe inflammatory changes were developing. These results suggest that MT-I and -II may play roles not only in protection of neurons from metals and free radicals ubiquitous in the inflammatory lesions but also in repair of injured neural tissues. -KEY WORDS: astrocyte, brain, canine, immunohistochemistry, metallothionein.

show abstract

Distribution of metallothionein in the human central nervous system

Cited by 78 publications

References 21 publications

Induction of metallothionein in astrocytes and microglia in the spinal cord from the myelin-deficient jimpy mouse

Induction of metallothionein in astrocytes and microglia in the spinal cord from the myelin-deficient jimpy mouse

Localization of Metallothioneins-I & -II and -III in the Brain of Aged Dog.

Localization of Metallothionein-I and -II in Hypertrophic Astrocytes in Brain Lesions of Dogs.

Contact Info

Product

Resources

About